🇺🇸 FDA
Patent

US 7790186

Plasmodium vivax hybrid circumsporozoite protein and vaccine

granted A61KA61K2039/55566A61K39/015

Quick answer

US patent 7790186 (Plasmodium vivax hybrid circumsporozoite protein and vaccine) held by The United States of America as represented by the Secretary of the Army expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/55566, A61K39/015, A61P, A61P33/02